Clinical Trials
40 trialsRF-2018-123683
IRCCS San Raffaele
EVENTIDE
University of Aberdeen
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
POELH-II
Erasmus Medical Center
HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca
PCW
Wake Forest University Health Sciences
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Osteosclerotic Changes on CT Predict Survival in Prostate Cancer
Sun Yat-sen University
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Genetic Studies of Prostate Cancer Aggressiveness and Prognosis
Karolinska Institutet
ROOT
Taproot Health
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
Alanya Alaaddin Keykubat University
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Memorial Sloan Kettering Cancer Center
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
University Hospital, Basel, Switzerland
BANN
University Medical Center Groningen
Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia
Daiichi Sankyo
HCC and FTC
The Catholic University of Korea
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Organon and Co
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Mayo Clinic
LAPC-NGS-A/001
Istituto Clinico Humanitas
NIRPA
Gary Onik MD
Genetic Analysis of Hereditary Prostate Cancer
National Institutes of Health Clinical Center (CC)
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
Edward-Elmhurst Health System
ChemoRenCan
University Hospital, Bordeaux
ALK
Instituto Nacional de Cancerologia de Mexico
PANC-CTC
University Hospital, Bordeaux
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Mayo Clinic
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
St. James's Hospital, Ireland
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
Edward-Elmhurst Health System
The Predictive Value of CT-PET in Esophageal Cancer
St. James's Hospital, Ireland
A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone
University Health Network, Toronto
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
Clinica Universidad de Navarra, Universidad de Navarra
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer
Stanford University
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
SRCC
University Hospital, Gasthuisberg
Correlation of PET-CT Studies With Serum Protein Analysis
Stanford University
Symptom Assessment With Patient Surveys
Stanford University
Novel Method of Surveillance in Barrett's Esophagus
Mayo Clinic
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma
KU Leuven